Celldex Therapeutics
CLDX
CLDX
131 hedge funds and large institutions have $172M invested in Celldex Therapeutics in 2018 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
6% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 17
3% less funds holding
Funds holding: 135 → 131 (-4)
23% less capital invested
Capital invested by funds: $223M → $172M (-$50.7M)
Holders
131
Holding in Top 10
2
Calls
$1.16M
Puts
$998K
Top Buyers
| 1 | +$16.8M | |
| 2 | +$4.16M | |
| 3 | +$2.24M | |
| 4 |
TA
Teachers Advisors
New York
|
+$1.49M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$1.11M |
Top Sellers
| 1 | -$6.05M | |
| 2 | -$5.9M | |
| 3 | -$3.85M | |
| 4 |
AC
Ascend Capital
Orinda,
California
|
-$2.48M |
| 5 |
AG
Artal Group
Luxembourg
|
-$995K |